SI3321355T1 - Postopki in sestavki za klinično izpeljavo alogenske celice in terapevtske uporabe - Google Patents

Postopki in sestavki za klinično izpeljavo alogenske celice in terapevtske uporabe

Info

Publication number: SI3321355T1
Authority: SI; Slovenia
Prior art keywords: compositions; methods; therapeutic uses; allogenic cell; derivation
Prior art date: 2011-12-30

Application number

SI201231950T

Other languages

English (en)

Inventor

Amit Patel

Original Assignee

Amit Patel

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-12-30

Filing date

2012-12-31

Publication date

2021-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48698707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3321355(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-12-31 Application filed by Amit Patel filed Critical Amit Patel

2021-11-30 Publication of SI3321355T1 publication Critical patent/SI3321355T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cell Biology (AREA)
Developmental Biology & Embryology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Gynecology & Obstetrics (AREA)
Cardiology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Virology (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)

SI201231950T 2011-12-30 2012-12-31 Postopki in sestavki za klinično izpeljavo alogenske celice in terapevtske uporabe SI3321355T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201161582070P	2011-12-30	2011-12-30
US201261591211P	2012-01-26	2012-01-26
EP17191442.7A EP3321355B1 (en)	2011-12-30	2012-12-31	Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses

Publications (1)

Publication Number	Publication Date
SI3321355T1 true SI3321355T1 (sl)	2021-11-30

Family

ID=48698707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201231950T SI3321355T1 (sl)	2011-12-30	2012-12-31	Postopki in sestavki za klinično izpeljavo alogenske celice in terapevtske uporabe

Country Status (12)

Country	Link
US (6)	US9803176B2 (sl)
EP (2)	EP2798058B1 (sl)
JP (1)	JP6548897B2 (sl)
CA (2)	CA2862661C (sl)
DK (1)	DK3321355T3 (sl)
ES (2)	ES2890126T3 (sl)
HR (1)	HRP20211373T1 (sl)
HU (1)	HUE056817T2 (sl)
PL (1)	PL3321355T3 (sl)
PT (1)	PT3321355T (sl)
SI (1)	SI3321355T1 (sl)
WO (1)	WO2013102219A1 (sl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2623940C (en)	2005-09-27	2017-01-10	Tissuetech, Inc.	Amniotic membrane preparations and purified compositions and methods of use
US9682044B2 (en)	2011-06-10	2017-06-20	Tissuetech, Inc.	Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
KR101662405B1 (ko)	2013-12-12	2016-10-05	사회복지법인 삼성생명공익재단	줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌혈관 질환 치료용 약학적 조성물
WO2015142061A1 (ko)	2014-03-18	2015-09-24	사회복지법인 삼성생명공익재단	줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌 염증성 질환의 치료용 조성물
JP2017517255A (ja) *	2014-05-21	2017-06-29	ミメディクスグループインコーポレイテッド	微粉化ホウォートンゼリー
TW201603818A (zh)	2014-06-03	2016-02-01	組織科技股份有限公司	組成物及方法
AU2015287920A1 (en)	2014-07-08	2017-01-19	Mimedx Group, Inc.	Micronized wharton's jelly
WO2016138025A2 (en)	2015-02-23	2016-09-01	Tissuetech, Inc.	Apparatuses and methods for treating ophthalmic diseases and disorders
US10342831B2 (en)	2015-05-20	2019-07-09	Tissuetech, Inc.	Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
ES2914692T3 (es)	2015-08-12	2022-06-15	Cha Biotech Co Ltd	Células madre adhesivas derivadas de cordón umbilical mejoradas, método de preparación para las mismas, y uso de las mismas
TW201733600A (zh)	2016-01-29	2017-10-01	帝聖工業公司	胎兒扶持組織物及使用方法
CA3029233A1 (en) *	2016-06-24	2017-12-28	Osiris Therapeutics, Inc.	Human tissue derived compositions and uses thereof
KR102048228B1 (ko)	2016-12-02	2019-11-25	가톨릭대학교 산학협력단	Ｔ 세포 자극용 엑소좀 및 이의 약제학적 용도
KR101864234B1 (ko) *	2017-07-04	2018-06-04	인하대학교 산학협력단	음경해면체 유래 엑소좀을 유효성분으로 포함하는, 발기부전 예방, 개선 또는 치료용 조성물
US11285177B2 (en)	2018-01-03	2022-03-29	Globus Medical, Inc.	Allografts containing viable cells and methods thereof
CN108239621B (zh) *	2018-01-24	2020-08-18	北京臻溪谷医学研究中心（有限合伙）	一种胎盘亚全能干细胞分离、扩增、冻存、复苏干细胞的方法
MX2023002726A (es) *	2020-09-08	2023-05-18	Amit Patel	Citoblastos alogenicos de cordón umbilical para el tratamiento de condiciones respiratorias graves.
US20230057957A1 (en) *	2021-08-23	2023-02-23	Therapeutic Solutions International, Inc.	Umbilical cord mesenchymal stem cells for treatment of chronic obstructive pulmonary disease and lung degeneration
WO2024006911A1 (en) *	2022-06-29	2024-01-04	FUJIFILM Holdings America Corporation	Ipsc-derived astrocytes and methods of use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5486359A (en)	1990-11-16	1996-01-23	Osiris Therapeutics, Inc.	Human mesenchymal stem cells
WO1999061587A1 (en)	1998-05-29	1999-12-02	Osiris Therapeutics, Inc.	Human cd45+ and/or fibroblast + mesenchymal stem cells
US20030161818A1 (en)	2002-02-25	2003-08-28	Kansas State University Research Foundation	Cultures, products and methods using stem cells
WO2004072273A1 (en)	2003-02-11	2004-08-26	Davies John E	Progenitor cells from wharton's jelly of human umbilical cord
ES2564044T3 (es)	2003-06-27	2016-03-17	DePuy Synthes Products, Inc.	Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas
PL1789534T3 (pl) *	2004-08-16	2015-03-31	Cellresearch Corp Pte Ltd	Wyodrębnienie komórek macierzystych/progenitorowych z błony owodniowej pępowiny
WO2007106089A1 (en)	2006-03-14	2007-09-20	Spherical Dynamics, Inc.	System for and method for psychological assessment
MX2009008563A (es) *	2007-02-12	2009-10-19	Anthrogenesis Corp	Tratamiento de padecimientos inflamatorios utilizando celulas madre placentarias.
PT103843B (pt) *	2007-10-04	2008-08-12	Medinfar Produtos Farmaceutico	Método de isolamento de células precursoras a partir do cordão umbilical humano
CA2743573C (en) *	2008-11-21	2021-04-27	Anthrogenesis Corporation	Treatment of diseases, disorders or conditions of the lung using placental cells
CN101748096B (zh)	2008-12-17	2013-03-13	北京汉氏联合生物技术有限公司	亚全能干细胞、其制备方法及其用途
EP2483392B1 (en) *	2009-09-23	2015-11-11	Davinci Biosciences LLC	Umbilical cord lining stem cells and methods and material for isolating and culturing same
CN101890050B (zh) *	2010-07-14	2012-07-04	江苏大学	脐带间质干细胞来源膜性囊泡及其应用
EP2540819A1 (en)	2011-06-27	2013-01-02	Rheinisch-Westfälische Technische Hochschule Aachen (RWTH)	Method for cultivating cells in platelet-lysate-containing medium

2012
- 2012-12-31 SI SI201231950T patent/SI3321355T1/sl unknown
- 2012-12-31 EP EP12862921.9A patent/EP2798058B1/en active Active
- 2012-12-31 ES ES17191442T patent/ES2890126T3/es active Active
- 2012-12-31 HU HUE17191442A patent/HUE056817T2/hu unknown
- 2012-12-31 PT PT171914427T patent/PT3321355T/pt unknown
- 2012-12-31 CA CA2862661A patent/CA2862661C/en active Active
- 2012-12-31 WO PCT/US2012/072331 patent/WO2013102219A1/en active Application Filing
- 2012-12-31 JP JP2014550544A patent/JP6548897B2/ja active Active
- 2012-12-31 ES ES12862921.9T patent/ES2656614T3/es active Active
- 2012-12-31 US US13/732,204 patent/US9803176B2/en active Active
- 2012-12-31 CA CA3113484A patent/CA3113484A1/en active Pending
- 2012-12-31 EP EP17191442.7A patent/EP3321355B1/en active Active
- 2012-12-31 DK DK17191442.7T patent/DK3321355T3/da active
- 2012-12-31 PL PL17191442T patent/PL3321355T3/pl unknown
2017
- 2017-10-31 US US15/799,743 patent/US20190218519A1/en not_active Abandoned
2021
- 2021-05-17 US US17/322,672 patent/US20220041992A1/en not_active Abandoned
- 2021-08-30 HR HRP20211373TT patent/HRP20211373T1/hr unknown
- 2021-12-22 US US17/559,583 patent/US20220251515A1/en active Pending
- 2021-12-22 US US17/559,545 patent/US20220251514A1/en active Pending
- 2021-12-22 US US17/559,539 patent/US20220251513A1/en active Pending

Also Published As

Publication number	Publication date
EP3321355B1 (en)	2021-08-25
EP2798058A1 (en)	2014-11-05
US20220041992A1 (en)	2022-02-10
US20220251515A1 (en)	2022-08-11
PL3321355T3 (pl)	2021-12-27
HRP20211373T1 (hr)	2021-11-26
EP2798058A4 (en)	2015-05-20
US20220251513A1 (en)	2022-08-11
US9803176B2 (en)	2017-10-31
EP2798058B1 (en)	2017-10-18
EP3321355A1 (en)	2018-05-16
JP6548897B2 (ja)	2019-07-24
PT3321355T (pt)	2021-09-28
ES2656614T3 (es)	2018-02-27
DK3321355T3 (da)	2021-11-08
ES2890126T3 (es)	2022-01-17
US20190218519A1 (en)	2019-07-18
HUE056817T2 (hu)	2022-03-28
CA2862661A1 (en)	2013-07-04
CA2862661C (en)	2021-05-25
US20130216505A1 (en)	2013-08-22
US20220251514A1 (en)	2022-08-11
JP2015503918A (ja)	2015-02-05
CA3113484A1 (en)	2013-07-04
WO2013102219A1 (en)	2013-07-04

Publication	Publication Date	Title
HUE056817T2 (hu)	2022-03-28	Eljárások és készítmények allogén sejt klinikai származtatására és terápiás alkalmazások
HK1209788A1 (en)	2016-04-08	Methods and compositions for the treatment of lysosomal storage diseases
EP2904106A4 (en)	2016-05-11	COMPOSITIONS AND METHODS FOR TARGETING STROMAL CELLS FOR THE TREATMENT OF CANCER
DK2608777T3 (en)	2019-10-28	Compositions and Methods for Cardiac Therapy
EP2847152A4 (en)	2016-03-23	COMPOSITIONS AND METHOD FOR THE TREATMENT OF METABOLIC SYNDROME
EP2736528A4 (en)	2015-03-18	COMPOSITIONS AND METHODS OF TREATING HIV
HK1253952A1 (zh)	2019-07-05	用於生成緻密tale-核酸酶的方法及其用途
HK1195332A1 (en)	2014-11-07	Devices and methods for culture of cells
ZA201402734B (en)	2021-05-26	Collector compositions and methods of using the same
EP2836224A4 (en)	2015-12-16	COMPOSITIONS OF BIOZOOSE AND RELATED METHODS
HK1204461A1 (en)	2015-11-20	Compositions and methods of use of phorbol esters for the treatment of stroke
SG11201400668SA (en)	2014-04-28	Wnt compositions and therapeutic uses of such compositions
EP2884984A4 (en)	2016-03-16	THERAPEUTIC COMPOSITIONS AND METHOD
EP2675478A4 (en)	2015-06-10	COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF GRIP
GB201200458D0 (en)	2012-02-22	Methods of preparing cells and compositions
EP2806894A4 (en)	2015-11-04	METHODS AND COMPOSITIONS FOR THERAPEUTICS
EP2844272A4 (en)	2015-11-04	METHOD AND COMPOSITIONS FOR INCREASING RED BLOOD BODIES
EP2709632A4 (en)	2015-03-04	COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES
HK1200355A1 (en)	2015-08-07	Treatment of red blood cells
EP2895186A4 (en)	2016-05-18	THERAPEUTIC COMPOSITIONS AND RELATED METHODS
ZA201408065B (en)	2016-04-28	Compositions and methods for the treatment of diabetes
EP3603631C0 (en)	2023-11-29	METHODS AND COMPOSITIONS FOR TREATING DIVERTICULOSIS
ZA201408053B (en)	2016-04-28	Compositions and methods for the treatment of metabolic syndrome
AU2012903646A0 (en)	2012-09-06	Therapeutic methods and compositions
AU2012901350A0 (en)	2012-04-26	Therapeutic methods and compositions